The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?

ALERT: A cyber incident at Optum/Change Healthcare may delay Luminis Health bill processing. Watch for fraud and verify any concerning messages with your provider's office. We are working to minimize disruptions.

Third Author not in Drupal

Charles Mylander

Title of the Project

The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?

Service Line not in Drupal

Surgery

Format of the Project

Journal Article

Affiliated Specialties not in Drupal

Breast

Name of Publication

Clinical Breast Cancer